Clinical trial
Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases
NCT00634582
Study timeline
Study start (unknown)2009-01-01Date precision: month
Registry last updated2018-07-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Cancerunresolved
Prostate Cancerunresolved
Interventions
paricalcitolDRUG · verified · RxNorm: paricalcitol
dual x-ray absorptometryPROCEDURE
quality-of-life assessmentPROCEDURE
Sponsors & collaborators
Wake Forest University Health Scienceslead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00634582 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.